X-132628513-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001394073.1(HS6ST2):c.1648G>T(p.Ala550Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00215 in 1,209,099 control chromosomes in the GnomAD database, including 5 homozygotes. There are 815 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.0014 ( 0 hom., 46 hem., cov: 22)
Exomes 𝑓: 0.0022 ( 5 hom. 769 hem. )
Consequence
HS6ST2
NM_001394073.1 missense
NM_001394073.1 missense
Scores
2
1
14
Clinical Significance
Conservation
PhyloP100: 4.75
Genes affected
HS6ST2 (HGNC:19133): (heparan sulfate 6-O-sulfotransferase 2) Heparan sulfate proteoglycans are ubiquitous components of the cell surface, extracellular matrix, and basement membranes, and interact with various ligands to influence cell growth, differentiation, adhesion, and migration. This gene encodes a member of the heparan sulfate (HS) sulfotransferase gene family, which catalyze the transfer of sulfate to HS. Different family members and isoforms are thought to synthesize heparan sulfates with tissue-specific structures and functions. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.013007343).
BP6
Variant X-132628513-C-A is Benign according to our data. Variant chrX-132628513-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 3038566.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Hemizygotes in GnomAd4 at 46 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HS6ST2 | NM_001394073.1 | c.1648G>T | p.Ala550Ser | missense_variant | 5/5 | ENST00000370833.7 | NP_001381002.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HS6ST2 | ENST00000370833.7 | c.1648G>T | p.Ala550Ser | missense_variant | 5/5 | 5 | NM_001394073.1 | ENSP00000359870 |
Frequencies
GnomAD3 genomes AF: 0.00141 AC: 157AN: 111057Hom.: 0 Cov.: 22 AF XY: 0.00138 AC XY: 46AN XY: 33245
GnomAD3 genomes
AF:
AC:
157
AN:
111057
Hom.:
Cov.:
22
AF XY:
AC XY:
46
AN XY:
33245
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00151 AC: 273AN: 180719Hom.: 0 AF XY: 0.00152 AC XY: 102AN XY: 67063
GnomAD3 exomes
AF:
AC:
273
AN:
180719
Hom.:
AF XY:
AC XY:
102
AN XY:
67063
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00223 AC: 2444AN: 1097991Hom.: 5 Cov.: 31 AF XY: 0.00212 AC XY: 769AN XY: 363459
GnomAD4 exome
AF:
AC:
2444
AN:
1097991
Hom.:
Cov.:
31
AF XY:
AC XY:
769
AN XY:
363459
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00141 AC: 157AN: 111108Hom.: 0 Cov.: 22 AF XY: 0.00138 AC XY: 46AN XY: 33306
GnomAD4 genome
AF:
AC:
157
AN:
111108
Hom.:
Cov.:
22
AF XY:
AC XY:
46
AN XY:
33306
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
13
ALSPAC
AF:
AC:
11
ESP6500AA
AF:
AC:
4
ESP6500EA
AF:
AC:
14
ExAC
AF:
AC:
183
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
HS6ST2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 16, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;.;T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.;L
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Benign
T
PROVEAN
Benign
N;N;.;.
REVEL
Benign
Sift
Benign
T;T;.;.
Sift4G
Benign
T;T;T;T
Polyphen
D;.;.;D
Vest4
MVP
MPC
0.70
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at